"Our own implicit biases come into play at times whether we like it or not, especially when it comes to frequently controversial medications."
How can we face the current pandemic while addressing the brain health crisis?
A patient, faced with a lung cancer diagnosis and the fear of death, goes through the stages of grief. How can you as clinicians lead them through?
What sleep disorders are common in older adults and what are the associated risk factors and correlates?
The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
Children with autism spectrum disorder have special educational needs, but with proper guidance they can flourish, even during a pandemic.
This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.
A diverse group of psychiatrists elaborates on the difficult conversation surrounding reparations, and why our society needs to pay attention.
Often misdiagnosed as other psychiatric disorders, FTD is the third most common type of dementia and the second most common among patients 65 years or younger. How to spot the signs.
“I have found that community involvement is really key to a sense of belonging and really feeding our soul as we think about maintaining our mental health.”
"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."
What are the challenges and opportunities for improvement in COVID-19-related mental health care?
Clinicians wrap up their discussion on novel, rapid-acting agents for major depressive disorder (MDD) with key insights and takeaways for providers.
Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
The key to addressing mental health may lie in business innovation theories.
A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.
In this CME article, learn more about the best practices for engaging patients in the informed consent process for psychedelic treatment and psychedelic-assisted psychotherapy.
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.
Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.
In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.
In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.
Tips for helping patients preserve their sobriety through the holiday season
Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?